These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31780678)

  • 1. Prognostic and therapeutic potential of Adenylate kinase 2 in lung adenocarcinoma.
    Liu H; Pu Y; Amina Q; Wang Q; Zhang M; Song J; Guo J; Mardan M
    Sci Rep; 2019 Nov; 9(1):17757. PubMed ID: 31780678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
    Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
    Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A co-expressed gene status of adenylate kinase 1/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma.
    Jan YH; Lai TC; Yang CJ; Huang MS; Hsiao M
    Sci Rep; 2019 Aug; 9(1):12329. PubMed ID: 31444368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 6. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma.
    Liang R; Xiao G; Wang M; Li X; Li Y; Hui Z; Sun X; Qin S; Zhang B; Du N; Liu D; Ren H
    Biomed Pharmacother; 2018 Nov; 107():1434-1446. PubMed ID: 30257360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
    Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
    Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
    Wei S; Zhang ZY; Fu SL; Xie JG; Liu XS; Xu YJ; Zhao JP; Xiong WN
    Cell Death Dis; 2016 Sep; 7(9):e2388. PubMed ID: 27685632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
    Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
    BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
    Liu M; Jiang L; Fu X; Wang W; Ma J; Tian T; Nan K; Liang X
    Cancer Sci; 2018 Oct; 109(10):3055-3067. PubMed ID: 30033530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircPUM1 promotes the malignant behavior of lung adenocarcinoma by regulating miR-326.
    Chen J; Xu S; Chen S; Zong Z; Han X; Zhao Y; Shang H
    Biochem Biophys Res Commun; 2019 Jan; 508(3):844-849. PubMed ID: 30528736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
    Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
    J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).
    Tan W; Liao Y; Qiu Y; Liu H; Tan D; Wu T; Tang M; Zhang S; Wang H
    Cancer Lett; 2018 Aug; 428():55-68. PubMed ID: 29702190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production.
    Fan J; Zhang X; Wang S; Chen W; Li Y; Zeng X; Wang Y; Luan J; Li L; Wang Z; Sun X; Shen B; Ju D
    Cell Death Dis; 2019 Aug; 10(9):626. PubMed ID: 31427566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK1 serves as a potential prognostic biomarker and target for lung cancer.
    Li M; He F; Zhang Z; Xiang Z; Hu D
    J Int Med Res; 2020 Feb; 48(2):300060519897508. PubMed ID: 32020821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
    Wang L; Meng Y; Zhang QY
    BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Goto D; Komeda K; Uwatoko N; Nakashima M; Koike M; Kawai K; Kodama Y; Miyazawa A; Tanaka I; Hase T; Morise M; Hasegawa Y; Kawabe T; Sato M
    Cancer Invest; 2020 Apr; 38(4):240-249. PubMed ID: 32212938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth.
    Kim H; Lee HJ; Oh Y; Choi SG; Hong SH; Kim HJ; Lee SY; Choi JW; Su Hwang D; Kim KS; Kim HJ; Zhang J; Youn HJ; Noh DY; Jung YK
    Nat Commun; 2014; 5():3351. PubMed ID: 24548998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.